Evaluation of Plasmodium vivax HAP2 as a transmission-blocking vaccine candidate. Qiu Y, Zhao Y, Liu F, Ye B, et al. Vaccine 2020 Feb 21. pii: S0264-410X(20)30184.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Qiu Y, Zhao Y, Liu F, Ye B, et al. Evaluation of Plasmodium vivax HAP2 as a transmission-blocking vaccine candidate. Vaccine 2020 Feb 21. pii: S0264-410X(20)30184.
PMID: 32093983